📰 Multivariable Cox News
Page 2 - Multivariable Cox News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multivariable Cox. Real-time updates on events, politics, business and more.
October 17, 2023
Non–guideline-concordant care for ovarian cancer was associated with higher all-cause and cancer-specific mortality, increased health care utilization, and increased Medicare expenditures, highlighting opportunities for improving cancer care in this vulnerable group.
October 10, 2023
SARS-CoV-2 infection may elevate risk for certain autoimmune disorders, suggests study. Regular post-COVID monitoring needed to detect and manage potential autoimmune consequences.
October 5, 2023
The European Society of Cardiology (ESC) inaugural session unfolded against the backdrop of Amsterdam, the Netherlands...
October 4, 2023
Earlier age at onset of nonalcoholic fatty liver disease was associated with an increased risk for cancer, mainly digestive and lung cancers, in a large cohort study.
August 31, 2023
LAAO and DOACs are effective for preventing ischemic events at 5 years in patients with nonvalvular atrial fibrillation and high bleeding risk.
August 3, 2023
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Heart failure (HF) is generally associated with poor quality of life (QoL). Limited data are available characterizing health-related QoL (HRQL) in Chinese patients with HF.
June 13, 2023
COVID-19 infection was associated with increased risk for diabetes, according to a recently published study.
June 12, 2023
In a large population based cohort study including more than 34,000 people in Korea, Eun Ju Cho and Goh Eun Chung investigate the impact of alcohol consumption on the development of hepatocellular carcinoma according to fasting serum glucose level.
May 2, 2023
Patients with locally advanced and low metastatic burden prostate cancer have similar oncologic outcomes when treated with ADT alone.
April 29, 2023
Men with locally advanced (T4 or N+) and metastatic low-burden prostate cancer treated with ADT alone have similar oncologic outcomes.